title: Regenerative medicine: transforming the drug discovery and development paradigm.
abstract: Despite the explosion of knowledge in basic biological processes controlling tissue regeneration and the growing interest in repairing/replacing diseased tissues and organs through various approaches (e.g., small and large molecule therapeutics, stem cell injection, tissue engineering), the pharmaceutical industry (pharma) has been reluctant to fully adopt these technologies into the traditional drug discovery and research and development (R&D) process. In this article, I discuss knowledge-base gaps and other possible factors that may delay full incorporation of these innovations in pharma R&D. I hope that this discussion will illuminate key issues that currently limit synergistic relationships between pharma and academic institutions and may even stimulate initiation of such collaborative research.
authors.affiliation: Cardiovascular & Metabolic Diseases, Gaithersburg, Maryland 20878.
authors.forename: Sotirios K
authors.initials: SK
authors.lastname: Karathanasis
mesh_terms: D064987:Cell- and Tissue-Based Therapy / Q000379:methods / Q000639:trends; D055808:Drug Discovery / Q000379:methods* / Q000639:trends; D004353:Drug Evaluation, Preclinical / Q000379:methods / Q000639:trends; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology; D044968:Regenerative Medicine / Q000379:methods* / Q000639:trends; D057905:Stem Cell Research
chemical_list: D036341:Intercellular Signaling Peptides and Proteins
references.citation: Dev Biol. 2011 Oct 15;358(2):278-84
references.pmid: 20561516
references.citation: Science. 1998 Nov 6;282(5391):1145-7
references.pmid: 9804556
references.citation: Clin Lab Med. 2011 Mar;31(1):109-23
references.pmid: 21295725
references.citation: Nat Rev Drug Discov. 2011 Jun 24;10(7):507-19
references.pmid: 21701501
references.citation: Nat Rev Drug Discov. 2011 Jun;10(6):428-38
references.pmid: 21629293
references.citation: Exp Cell Res. 2008 Jun 10;314(9):1937-44
references.pmid: 18439579
references.citation: Nature. 2011 Jun 08;474(7353):640-4
references.pmid: 21654746
references.citation: Int J Biochem Cell Biol. 2011 Jun;43(6):843-6
references.pmid: 21458591
references.citation: Nat Med. 2011 Jul 31;17(8):952-60
references.pmid: 21804539
references.citation: Clin Pharmacol Ther. 2011 Oct;90(4):499-501
references.pmid: 21934722
references.citation: Circ Res. 2011 Dec 9;109(12):1415-28
references.pmid: 22158649
references.citation: Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13380-5
references.pmid: 22847442
references.citation: PLoS One. 2012;7(5):e37004
references.pmid: 22623968
references.citation: Cell Stem Cell. 2012 Aug 3;11(2):242-52
references.pmid: 22862949
references.citation: Sci Signal. 2012 Jun 05;5(227):ra41
references.pmid: 22669846
references.citation: Nature. 2012 Jan 18;481(7381):295-305
references.pmid: 22258608
references.citation: Cell. 2006 Aug 25;126(4):663-76
references.pmid: 16904174
references.citation: Regen Med. 2012 Jul;7(4):571-82
references.pmid: 22817629
references.citation: Drug Discov Today. 2008 Mar;13(5-6):227-33
references.pmid: 18342798
references.citation: Circ Res. 2012 Jun 8;110(12):1628-45
references.pmid: 22679138
references.citation: J Biomol Screen. 2012 Oct;17(9):1117-27
references.pmid: 22853930
references.citation: Nat Rev Drug Discov. 2004 Aug;3(8):711-5
references.pmid: 15286737
references.citation: Mt Sinai J Med. 2010 Jul-Aug;77(4):327-32
references.pmid: 20687177
references.citation: Science. 2011 Feb 25;331(6020):1078-80
references.pmid: 21350179
references.citation: Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10921-6
references.pmid: 22711842
references.citation: Drug Discov Today. 2010 Aug;15(15-16):587-9
references.pmid: 20546921
references.citation: Circ Res. 2012 Nov 9;111(11):1434-45
references.pmid: 22931954
references.citation: Stem Cells. 2012 Jan;30(1):42-7
references.pmid: 21898694
references.citation: Circ Res. 2011 Dec 9;109(12):1363-74
references.pmid: 22034491
references.citation: Nat Rev Drug Discov. 2012 Mar 01;11(3):191-200
references.pmid: 22378269
references.citation: Regen Med. 2010 Sep;5(5):687-90
references.pmid: 20868323
references.citation: Sci Transl Med. 2012 Aug 8;4(146):146ra109
references.pmid: 22875829
references.citation: Vox Sang. 2010 Feb;98(2):93-107
references.pmid: 19663934
references.citation: N Engl J Med. 2006 Oct 19;355(16):1730-5
references.pmid: 17050899
references.citation: Lancet. 2012 Mar 10;379(9819):933-942
references.pmid: 22405796
references.citation: Heart. 2012 Mar;98(6):443-9
references.pmid: 22285968
references.citation: Circ Res. 2012 May 25;110(11):1392-4
references.pmid: 22628569
references.citation: Regen Med. 2012 Jul;7(4):523-33
references.pmid: 22817626
references.citation: Chem Biol. 2011 Dec 23;18(12):1658-68
references.pmid: 22195568
references.citation: Cell Stem Cell. 2010 Jun 4;6(6):517-20
references.pmid: 20569688
references.citation: Arch Toxicol. 2011 Feb;85(2):79-117
references.pmid: 21225242
references.citation: Cell Cycle. 2012 Aug 15;11(16):2959-60
references.pmid: 22926561
references.citation: Nat Rev Drug Discov. 2011 Nov 11;10(12):915-29
references.pmid: 22076509
references.citation: Nat Cell Biol. 2012 Jan 15;14(2):209-19
references.pmid: 22246346
references.citation: Regen Med. 2012 Jul;7(4):455-62
references.pmid: 22817619
references.citation: Vascul Pharmacol. 2013 Mar;58(3):164-73
references.pmid: 22902355